Painchek Ltd Announces CEO Transition
Key points
- Philip Daffas has stepped down as CEO and Managing Director
- Andy Hoggan appointed as Interim CEO
- Transition supports FY2027 strategy and US market development
Full summary
PainChek Ltd, developer of the world's first AI-powered pain assessment and monitoring application, announced that Philip Daffas will cease to serve as CEO and Managing Director effective immediately. This transition supports PainChek's Financial Year 2027 strategy following FDA De Novo clearance. The Board thanks Philip for his ten years of leadership and wishes him well in his next endeavors. Andy Hoggan, currently COO, will act as Interim CEO during the transition period. The Board expects to announce a new CEO in due course.
Summary generated by a large language model. Please interpret with care.